← Evidence map

TrialCancer chemotherapy and pharmacology2022

A clinical scoring tool validated with machine learning for predicting severe hand-foot syndrome from sorafenib in hepatocellular carcinoma.

Ahmad Y Abuhelwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35226112